IraATeplerMD

Gastroenterology • Bronx, NY

Asst Clin Prof, Medicine, Gastroenterology & Liver Diseases, Albert Einstein College of Medicine

Join to view full profile

Dr. Tepler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Tepler's full profile

Already have an account?

Office
3333 Henry Hudson Pkwy
Ste 1
Bronx, NY 10463
Phone+1 718-796-1000

Fax+1 718-796-2124
Is this information wrong?

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Wakefield Campus)Fellowship, Gastroenterology, 1994 - 1996
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1991 - 1994
Columbia University Vagelos College of Physicians and SurgeonsClass of 1991

Certifications & Licensure

NY State Medical License 1993 - 2026
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

1 citations
Endometriosis with colonic wall invasion.
Jordan J. Karlitz, Ira A. Tepler, Kathryn E. Tanaka> ;Clinical Gastroenterology and Hepatology. 2007 Mar 1
Low-dose vincristine-associated bilateral vocal cord paralysis.
Ryan, S. P., DelPrete, S. A., Weinstein, P. W., Erichson, R. B., Bar, M. H., Lo, K. M., Cohen, N. S., Tepler, I.> ;Conn Med. 1999 Oct
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer.
Seidman, A. D., Hudis, C. A., Albanell, J., Albanel, J., Tong, W., Tepler, I., Currie, V., Moynahan, M. E., Theodoulou, M., Gollub, M., Baselga, J., Norton, L.> ;J Clin Oncol. 1998 Oct
Psychological support to an autologous bone marrow transplant unit in a community hospital: a pilot experience.
Amato, J. J., Williams, M., Greenberg, C., Bar, M., Lo, S., Tepler, I.> ;Psychooncology. 1998 May 20
Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer.
Seidman, A. D., Hudis, C. A., McCaffrey, J., Tong, W., Currie, V., Moynahan, M. E., Theodoulou, M., Tepler, I., Gollub, M., Norton, L.> ;Semin Oncol. 1997 Oct
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Wheeler, C., Eickhoff, C., Elias, A., Ibrahim, J., Ayash, L., McCauley, M., Mauch, P., Schwartz, G., Eder, J. P., Mazanet, R., Ferrara, J., Rimm, I. J., Guinan, E., Bi...> ;Biol Blood Marrow Transplant. 1997 Jun
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
Tepler, I., Elias, L., Smith, J. W., Hussein, M., Rosen, G., Chang, A. Y., Moore, J. O., Gordon, M. S., Kuca, B., Beach, K. J., Loewy, J. W., Garnick, M. B., Kaye, J. A.> ;Blood. 1996 May 1
Intensive combined modality therapy for limited-stage small-cell lung cancer.
Elias, A. D., Ayash, L., Frei, E., Skarin, A. T., Hunt, M., Wheeler, C., Schwartz, G., Mazanet, R., Tepler, I., Eder, J. P.> ;J Natl Cancer Inst. 1993 Apr 7
Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy.
Tepler, I., Schwartz, G., Parker, K., Charette, J., Kadin, M. E., Woodworth, T. G., Schnipper, L. E.> ;Cancer. 1994 Feb 15
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.
Tepler, I., Cannistra, S. A., Frei, E., Gonin, R., Anderson, K. C., Demetri, G., Niloff, J., Goodman, H., Muntz, H., Muto, M.> ;J Clin Oncol. 1993 Aug
High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer.
Elias, A. D., Ayash, L., Skarin, A. T., Wheeler, C., Schwartz, G., Mazanet, R., Tepler, I., Schnipper, L., Frei, E., Antman, K. H.> ;Chest. 1993 Apr
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.
Elias, A. D., Ayash, L. J., Wheeler, C., Schwartz, G., Tepler, I., McCauley, M., Mazanet, R., Schnipper, L., Frei, E., Antman, K. H.> ;Semin Oncol. 1994 Oct
Effect of recombinant human interleukin-3 on haematological recovery from chemotherapy-induced myelosuppression.
Tepler, I., Elias, A., Kalish, L., Shulman, L., Strauss, G., Skarin, A., Lynch, T., Levitt, D., Resta, D., Demetri, G.> ;Br J Haematol. 1994 Aug
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
Ayash, L. J., Elias, A., Hunt, M., Demetri, G., Wheeler, C., Tepler, I., Schwartz, G., Mazanet, R., Reich, E., McCauley, M.> ;Br J Haematol. 1994 May
High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Ayash, L. J., Elias, A., Wheeler, C., Tepler, I., Schwartz, G., Schnipper, L., Frei, E., Antman, K.> ;J Hematother. 1993
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Elias, A. D., Ayash, L. J., Wheeler, C., Schwartz, G., Tepler, I., Gonin, R., McCauley, M., Mazanet, R., Schnipper, L., Frei, E.> ;Bone Marrow Transplant. 1995 Mar
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therap...
Antman, K., Ayash, L., Elias, A., Wheeler, C., Schwartz, G., Mazanet, R., Tepler, I., Schnipper, L. E., Frei, E.> ;J Natl Cancer Inst Monogr. 1994
The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose c...
Elias, A. D., Ayash, L., Tepler, I., Wheeler, C., Schwartz, G., Mazanet, R., Schnipper, L., Frei, E., Antman, K.> ;J Hematother. 1993
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.
Ayash, L. J., Elias, A., Wheeler, C., Reich, E., Schwartz, G., Mazanet, R., Tepler, I., Warren, D., Lynch, C., Gonin, R.> ;J Clin Oncol. 1994 Jan
Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemia.
Maziarz, R. T., Tepler, I., Antin, J. H., Keroack, M. A., Churchill, W. H., Holmes, W., Rappeport, J.> ;Ann Intern Med. 1988 Aug 15
Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.
Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., Leder, P.> ;Cell. 1987 May 22
Human and rat mast cell high-affinity immunoglobulin E receptors: characterization of putative alpha-chain gene products.
Shimizu, A., Tepler, I., Benfey, P. N., Berenstein, E. H., Siraganian, R. P., Leder, P.> ;Proc Natl Acad Sci U S A. 1988 Mar
Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncoge...
Pattengale, P. K., Stewart, T. A., Leder, A., Sinn, E., Muller, W., Tepler, I., Schmidt, E., Leder, P.> ;Am J Pathol. 1989 Jul
The gene for the human mast cell high-affinity IgE receptor alpha chain: chromosomal localization to Iq21-q23 and RFLP analysis.
Tepler, I., Morton, C. C., Shimizu, A., Holcombe, R. F., Eddy, R., Shows, T. B., Leder, P.> ;Am J Hum Genet. 1989 Nov
The gene for the rat mast cell high affinity IgE receptor alpha chain. Structure and alternative mRNA splicing patterns.
Tepler, I., Shimizu, A., Leder, P.> ;J Biol Chem. 1989 Apr 5
Join now to see all

Hospital Affiliations

Burke Rehabilitation HospitalWhite Plains, New York
Montefiore Medical CenterBronx, New York